Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

Atrium Therapeutics, Inc.NASDAQ: RNA

Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Free cash flow of -$33.24M in Q1 FY2026

Q1 FY2026 free cash flow was -$33.24M.

Context

  • Free cash flow amounted to 228.7% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$33.24M+65.1% QoQ
Last fiscal yearDec 2025
-$42.57M— YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
(42.57M) USD
Year-over-year change
—

Free Cash Flow vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Free Cash Flow figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.